HIGHLIGHTS
- who: Report and colleagues from the Family Medicine, Poznan University of Medical Sciences, Poznan, POL Internal Medicine, Alfaisal University have published the research work: Review began 09/06/2022 Review ended 10/10/2022 Published 10/15/2022 u00a9 Copyright, in the Journal: (JOURNAL) of October/15,/2022
- what: The aim of the threeyear-long clinical trial was to assess the link between Sjogren`s syndrome and the quality of life.
- future: Disease-modifying antirheumatic drugs (DMARDs) have questionable effectiveness though more studies are needed.
SUMMARY
There is more . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.